Global Terbinafine (Lamisil) Market Insights and Forecast to 2028

Global Terbinafine (Lamisil) Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Terbinafine (Lamisil) Product Introduction
1.2 Market by Type
1.2.1 Global Terbinafine (Lamisil) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 External Use
1.3 Market by Application
1.3.1 Global Terbinafine (Lamisil) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Fungal Infection Of The Skin And Mucous Membrane
1.3.3 Onychomycosis
1.3.4 Bronchial Asthma
1.3.5 Gynecological Anti-Infection Preparation
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Terbinafine (Lamisil) Sales Estimates and Forecasts 2017-2028
2.2 Global Terbinafine (Lamisil) Revenue Estimates and Forecasts 2017-2028
2.3 Global Terbinafine (Lamisil) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Terbinafine (Lamisil) Sales by Region
2.4.1 Global Terbinafine (Lamisil) Sales by Region (2017-2022)
2.4.2 Global Sales Terbinafine (Lamisil) by Region (2023-2028)
2.5 Global Terbinafine (Lamisil) Revenue by Region
2.5.1 Global Terbinafine (Lamisil) Revenue by Region (2017-2022)
2.5.2 Global Terbinafine (Lamisil) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Terbinafine (Lamisil) Sales by Manufacturers
3.1.1 Global Top Terbinafine (Lamisil) Manufacturers by Sales (2017-2022)
3.1.2 Global Terbinafine (Lamisil) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Terbinafine (Lamisil) in 2021
3.2 Global Terbinafine (Lamisil) Revenue by Manufacturers
3.2.1 Global Terbinafine (Lamisil) Revenue by Manufacturers (2017-2022)
3.2.2 Global Terbinafine (Lamisil) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Terbinafine (Lamisil) Revenue in 2021
3.3 Global Terbinafine (Lamisil) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Terbinafine (Lamisil) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Terbinafine (Lamisil) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Terbinafine (Lamisil) Sales by Type
4.1.1 Global Terbinafine (Lamisil) Historical Sales by Type (2017-2022)
4.1.2 Global Terbinafine (Lamisil) Forecasted Sales by Type (2023-2028)
4.1.3 Global Terbinafine (Lamisil) Sales Market Share by Type (2017-2028)
4.2 Global Terbinafine (Lamisil) Revenue by Type
4.2.1 Global Terbinafine (Lamisil) Historical Revenue by Type (2017-2022)
4.2.2 Global Terbinafine (Lamisil) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Terbinafine (Lamisil) Revenue Market Share by Type (2017-2028)
4.3 Global Terbinafine (Lamisil) Price by Type
4.3.1 Global Terbinafine (Lamisil) Price by Type (2017-2022)
4.3.2 Global Terbinafine (Lamisil) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Terbinafine (Lamisil) Sales by Application
5.1.1 Global Terbinafine (Lamisil) Historical Sales by Application (2017-2022)
5.1.2 Global Terbinafine (Lamisil) Forecasted Sales by Application (2023-2028)
5.1.3 Global Terbinafine (Lamisil) Sales Market Share by Application (2017-2028)
5.2 Global Terbinafine (Lamisil) Revenue by Application
5.2.1 Global Terbinafine (Lamisil) Historical Revenue by Application (2017-2022)
5.2.2 Global Terbinafine (Lamisil) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Terbinafine (Lamisil) Revenue Market Share by Application (2017-2028)
5.3 Global Terbinafine (Lamisil) Price by Application
5.3.1 Global Terbinafine (Lamisil) Price by Application (2017-2022)
5.3.2 Global Terbinafine (Lamisil) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Terbinafine (Lamisil) Market Size by Type
6.1.1 North America Terbinafine (Lamisil) Sales by Type (2017-2028)
6.1.2 North America Terbinafine (Lamisil) Revenue by Type (2017-2028)
6.2 North America Terbinafine (Lamisil) Market Size by Application
6.2.1 North America Terbinafine (Lamisil) Sales by Application (2017-2028)
6.2.2 North America Terbinafine (Lamisil) Revenue by Application (2017-2028)
6.3 North America Terbinafine (Lamisil) Market Size by Country
6.3.1 North America Terbinafine (Lamisil) Sales by Country (2017-2028)
6.3.2 North America Terbinafine (Lamisil) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Terbinafine (Lamisil) Market Size by Type
7.1.1 Europe Terbinafine (Lamisil) Sales by Type (2017-2028)
7.1.2 Europe Terbinafine (Lamisil) Revenue by Type (2017-2028)
7.2 Europe Terbinafine (Lamisil) Market Size by Application
7.2.1 Europe Terbinafine (Lamisil) Sales by Application (2017-2028)
7.2.2 Europe Terbinafine (Lamisil) Revenue by Application (2017-2028)
7.3 Europe Terbinafine (Lamisil) Market Size by Country
7.3.1 Europe Terbinafine (Lamisil) Sales by Country (2017-2028)
7.3.2 Europe Terbinafine (Lamisil) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Terbinafine (Lamisil) Market Size by Type
8.1.1 Asia Pacific Terbinafine (Lamisil) Sales by Type (2017-2028)
8.1.2 Asia Pacific Terbinafine (Lamisil) Revenue by Type (2017-2028)
8.2 Asia Pacific Terbinafine (Lamisil) Market Size by Application
8.2.1 Asia Pacific Terbinafine (Lamisil) Sales by Application (2017-2028)
8.2.2 Asia Pacific Terbinafine (Lamisil) Revenue by Application (2017-2028)
8.3 Asia Pacific Terbinafine (Lamisil) Market Size by Region
8.3.1 Asia Pacific Terbinafine (Lamisil) Sales by Region (2017-2028)
8.3.2 Asia Pacific Terbinafine (Lamisil) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Terbinafine (Lamisil) Market Size by Type
9.1.1 Latin America Terbinafine (Lamisil) Sales by Type (2017-2028)
9.1.2 Latin America Terbinafine (Lamisil) Revenue by Type (2017-2028)
9.2 Latin America Terbinafine (Lamisil) Market Size by Application
9.2.1 Latin America Terbinafine (Lamisil) Sales by Application (2017-2028)
9.2.2 Latin America Terbinafine (Lamisil) Revenue by Application (2017-2028)
9.3 Latin America Terbinafine (Lamisil) Market Size by Country
9.3.1 Latin America Terbinafine (Lamisil) Sales by Country (2017-2028)
9.3.2 Latin America Terbinafine (Lamisil) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Terbinafine (Lamisil) Market Size by Type
10.1.1 Middle East and Africa Terbinafine (Lamisil) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Terbinafine (Lamisil) Revenue by Type (2017-2028)
10.2 Middle East and Africa Terbinafine (Lamisil) Market Size by Application
10.2.1 Middle East and Africa Terbinafine (Lamisil) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Terbinafine (Lamisil) Revenue by Application (2017-2028)
10.3 Middle East and Africa Terbinafine (Lamisil) Market Size by Country
10.3.1 Middle East and Africa Terbinafine (Lamisil) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Terbinafine (Lamisil) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Perrigo
11.1.1 Perrigo Corporation Information
11.1.2 Perrigo Overview
11.1.3 Perrigo Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Perrigo Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Perrigo Recent Developments
11.2 Novartis Pharmaceuticals Corporation
11.2.1 Novartis Pharmaceuticals Corporation Corporation Information
11.2.2 Novartis Pharmaceuticals Corporation Overview
11.2.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Pharmaceuticals Corporation Recent Developments
11.3 Gokul Pharma
11.3.1 Gokul Pharma Corporation Information
11.3.2 Gokul Pharma Overview
11.3.3 Gokul Pharma Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Gokul Pharma Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Gokul Pharma Recent Developments
11.4 TEVA
11.4.1 TEVA Corporation Information
11.4.2 TEVA Overview
11.4.3 TEVA Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 TEVA Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 TEVA Recent Developments
11.5 Mylan Pharmaceuticals
11.5.1 Mylan Pharmaceuticals Corporation Information
11.5.2 Mylan Pharmaceuticals Overview
11.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mylan Pharmaceuticals Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Pharmaceuticals Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Sivem Pharmaceuticals
11.7.1 Sivem Pharmaceuticals Corporation Information
11.7.2 Sivem Pharmaceuticals Overview
11.7.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sivem Pharmaceuticals Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sivem Pharmaceuticals Recent Developments
11.8 Apotex Corporation
11.8.1 Apotex Corporation Corporation Information
11.8.2 Apotex Corporation Overview
11.8.3 Apotex Corporation Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Apotex Corporation Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Apotex Corporation Recent Developments
11.9 Auro Pharma Inc
11.9.1 Auro Pharma Inc Corporation Information
11.9.2 Auro Pharma Inc Overview
11.9.3 Auro Pharma Inc Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Auro Pharma Inc Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Auro Pharma Inc Recent Developments
11.10 PLIVA
11.10.1 PLIVA Corporation Information
11.10.2 PLIVA Overview
11.10.3 PLIVA Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 PLIVA Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 PLIVA Recent Developments
11.11 Jamp Pharma Corporation
11.11.1 Jamp Pharma Corporation Corporation Information
11.11.2 Jamp Pharma Corporation Overview
11.11.3 Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Jamp Pharma Corporation Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jamp Pharma Corporation Recent Developments
11.12 Nu Pharm
11.12.1 Nu Pharm Corporation Information
11.12.2 Nu Pharm Overview
11.12.3 Nu Pharm Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Nu Pharm Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Nu Pharm Recent Developments
11.13 Codal Synto
11.13.1 Codal Synto Corporation Information
11.13.2 Codal Synto Overview
11.13.3 Codal Synto Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Codal Synto Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Codal Synto Recent Developments
11.14 Qd Pharmaceuticals
11.14.1 Qd Pharmaceuticals Corporation Information
11.14.2 Qd Pharmaceuticals Overview
11.14.3 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Qd Pharmaceuticals Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Qd Pharmaceuticals Recent Developments
11.15 Pharmel Inc
11.15.1 Pharmel Inc Corporation Information
11.15.2 Pharmel Inc Overview
11.15.3 Pharmel Inc Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Pharmel Inc Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Pharmel Inc Recent Developments
11.16 Smaart Pharmaceutticals
11.16.1 Smaart Pharmaceutticals Corporation Information
11.16.2 Smaart Pharmaceutticals Overview
11.16.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Smaart Pharmaceutticals Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Smaart Pharmaceutticals Recent Developments
11.17 Qilu Pharmaceutical
11.17.1 Qilu Pharmaceutical Corporation Information
11.17.2 Qilu Pharmaceutical Overview
11.17.3 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Qilu Pharmaceutical Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Qilu Pharmaceutical Recent Developments
11.18 Qingdao Jinfeng Pharmaceutical
11.18.1 Qingdao Jinfeng Pharmaceutical Corporation Information
11.18.2 Qingdao Jinfeng Pharmaceutical Overview
11.18.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Qingdao Jinfeng Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Terbinafine (Lamisil) Industry Chain Analysis
12.2 Terbinafine (Lamisil) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Terbinafine (Lamisil) Production Mode & Process
12.4 Terbinafine (Lamisil) Sales and Marketing
12.4.1 Terbinafine (Lamisil) Sales Channels
12.4.2 Terbinafine (Lamisil) Distributors
12.5 Terbinafine (Lamisil) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Terbinafine (Lamisil) Industry Trends
13.2 Terbinafine (Lamisil) Market Drivers
13.3 Terbinafine (Lamisil) Market Challenges
13.4 Terbinafine (Lamisil) Market Restraints
14 Key Findings in The Global Terbinafine (Lamisil) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Terbinafine (Lamisil) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of External Use
Table 4. Global Terbinafine (Lamisil) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Terbinafine (Lamisil) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Terbinafine (Lamisil) Sales by Region (2017-2022) & (KG)
Table 7. Global Terbinafine (Lamisil) Sales Market Share by Region (2017-2022)
Table 8. Global Terbinafine (Lamisil) Sales by Region (2023-2028) & (KG)
Table 9. Global Terbinafine (Lamisil) Sales Market Share by Region (2023-2028)
Table 10. Global Terbinafine (Lamisil) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Terbinafine (Lamisil) Revenue Market Share by Region (2017-2022)
Table 12. Global Terbinafine (Lamisil) Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Terbinafine (Lamisil) Revenue Market Share by Region (2023-2028)
Table 14. Global Terbinafine (Lamisil) Sales by Manufacturers (2017-2022) & (KG)
Table 15. Global Terbinafine (Lamisil) Sales Share by Manufacturers (2017-2022)
Table 16. Global Terbinafine (Lamisil) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Terbinafine (Lamisil) Revenue Share by Manufacturers (2017-2022)
Table 18. Terbinafine (Lamisil) Price by Manufacturers (2017-2022) &(US$/G)
Table 19. Global Terbinafine (Lamisil) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Terbinafine (Lamisil) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Terbinafine (Lamisil) as of 2021)
Table 21. Terbinafine (Lamisil) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Terbinafine (Lamisil) Product Offered
Table 23. Date of Manufacturers Enter into Terbinafine (Lamisil) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Terbinafine (Lamisil) Sales by Type (2017-2022) & (KG)
Table 26. Global Terbinafine (Lamisil) Sales by Type (2023-2028) & (KG)
Table 27. Global Terbinafine (Lamisil) Sales Share by Type (2017-2022)
Table 28. Global Terbinafine (Lamisil) Sales Share by Type (2023-2028)
Table 29. Global Terbinafine (Lamisil) Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Terbinafine (Lamisil) Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Terbinafine (Lamisil) Revenue Share by Type (2017-2022)
Table 32. Global Terbinafine (Lamisil) Revenue Share by Type (2023-2028)
Table 33. Terbinafine (Lamisil) Price by Type (2017-2022) & (US$/G)
Table 34. Global Terbinafine (Lamisil) Price Forecast by Type (2023-2028) & (US$/G)
Table 35. Global Terbinafine (Lamisil) Sales by Application (2017-2022) & (KG)
Table 36. Global Terbinafine (Lamisil) Sales by Application (2023-2028) & (KG)
Table 37. Global Terbinafine (Lamisil) Sales Share by Application (2017-2022)
Table 38. Global Terbinafine (Lamisil) Sales Share by Application (2023-2028)
Table 39. Global Terbinafine (Lamisil) Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Terbinafine (Lamisil) Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Terbinafine (Lamisil) Revenue Share by Application (2017-2022)
Table 42. Global Terbinafine (Lamisil) Revenue Share by Application (2023-2028)
Table 43. Terbinafine (Lamisil) Price by Application (2017-2022) & (US$/G)
Table 44. Global Terbinafine (Lamisil) Price Forecast by Application (2023-2028) & (US$/G)
Table 45. North America Terbinafine (Lamisil) Sales by Type (2017-2022) & (KG)
Table 46. North America Terbinafine (Lamisil) Sales by Type (2023-2028) & (KG)
Table 47. North America Terbinafine (Lamisil) Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Terbinafine (Lamisil) Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Terbinafine (Lamisil) Sales by Application (2017-2022) & (KG)
Table 50. North America Terbinafine (Lamisil) Sales by Application (2023-2028) & (KG)
Table 51. North America Terbinafine (Lamisil) Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Terbinafine (Lamisil) Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Terbinafine (Lamisil) Sales by Country (2017-2022) & (KG)
Table 54. North America Terbinafine (Lamisil) Sales by Country (2023-2028) & (KG)
Table 55. North America Terbinafine (Lamisil) Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Terbinafine (Lamisil) Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Terbinafine (Lamisil) Sales by Type (2017-2022) & (KG)
Table 58. Europe Terbinafine (Lamisil) Sales by Type (2023-2028) & (KG)
Table 59. Europe Terbinafine (Lamisil) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Terbinafine (Lamisil) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Terbinafine (Lamisil) Sales by Application (2017-2022) & (KG)
Table 62. Europe Terbinafine (Lamisil) Sales by Application (2023-2028) & (KG)
Table 63. Europe Terbinafine (Lamisil) Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Terbinafine (Lamisil) Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Terbinafine (Lamisil) Sales by Country (2017-2022) & (KG)
Table 66. Europe Terbinafine (Lamisil) Sales by Country (2023-2028) & (KG)
Table 67. Europe Terbinafine (Lamisil) Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Terbinafine (Lamisil) Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Terbinafine (Lamisil) Sales by Type (2017-2022) & (KG)
Table 70. Asia Pacific Terbinafine (Lamisil) Sales by Type (2023-2028) & (KG)
Table 71. Asia Pacific Terbinafine (Lamisil) Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Terbinafine (Lamisil) Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Terbinafine (Lamisil) Sales by Application (2017-2022) & (KG)
Table 74. Asia Pacific Terbinafine (Lamisil) Sales by Application (2023-2028) & (KG)
Table 75. Asia Pacific Terbinafine (Lamisil) Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Terbinafine (Lamisil) Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Terbinafine (Lamisil) Sales by Region (2017-2022) & (KG)
Table 78. Asia Pacific Terbinafine (Lamisil) Sales by Region (2023-2028) & (KG)
Table 79. Asia Pacific Terbinafine (Lamisil) Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Terbinafine (Lamisil) Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Terbinafine (Lamisil) Sales by Type (2017-2022) & (KG)
Table 82. Latin America Terbinafine (Lamisil) Sales by Type (2023-2028) & (KG)
Table 83. Latin America Terbinafine (Lamisil) Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Terbinafine (Lamisil) Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Terbinafine (Lamisil) Sales by Application (2017-2022) & (KG)
Table 86. Latin America Terbinafine (Lamisil) Sales by Application (2023-2028) & (KG)
Table 87. Latin America Terbinafine (Lamisil) Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Terbinafine (Lamisil) Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Terbinafine (Lamisil) Sales by Country (2017-2022) & (KG)
Table 90. Latin America Terbinafine (Lamisil) Sales by Country (2023-2028) & (KG)
Table 91. Latin America Terbinafine (Lamisil) Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Terbinafine (Lamisil) Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Terbinafine (Lamisil) Sales by Type (2017-2022) & (KG)
Table 94. Middle East and Africa Terbinafine (Lamisil) Sales by Type (2023-2028) & (KG)
Table 95. Middle East and Africa Terbinafine (Lamisil) Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Terbinafine (Lamisil) Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Terbinafine (Lamisil) Sales by Application (2017-2022) & (KG)
Table 98. Middle East and Africa Terbinafine (Lamisil) Sales by Application (2023-2028) & (KG)
Table 99. Middle East and Africa Terbinafine (Lamisil) Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Terbinafine (Lamisil) Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Terbinafine (Lamisil) Sales by Country (2017-2022) & (KG)
Table 102. Middle East and Africa Terbinafine (Lamisil) Sales by Country (2023-2028) & (KG)
Table 103. Middle East and Africa Terbinafine (Lamisil) Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Terbinafine (Lamisil) Revenue by Country (2023-2028) & (US$ Million)
Table 105. Perrigo Corporation Information
Table 106. Perrigo Description and Major Businesses
Table 107. Perrigo Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 108. Perrigo Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Perrigo Recent Developments
Table 110. Novartis Pharmaceuticals Corporation Corporation Information
Table 111. Novartis Pharmaceuticals Corporation Description and Major Businesses
Table 112. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 113. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Novartis Pharmaceuticals Corporation Recent Developments
Table 115. Gokul Pharma Corporation Information
Table 116. Gokul Pharma Description and Major Businesses
Table 117. Gokul Pharma Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 118. Gokul Pharma Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Gokul Pharma Recent Developments
Table 120. TEVA Corporation Information
Table 121. TEVA Description and Major Businesses
Table 122. TEVA Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 123. TEVA Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. TEVA Recent Developments
Table 125. Mylan Pharmaceuticals Corporation Information
Table 126. Mylan Pharmaceuticals Description and Major Businesses
Table 127. Mylan Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 128. Mylan Pharmaceuticals Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Mylan Pharmaceuticals Recent Developments
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Major Businesses
Table 132. Pfizer Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 133. Pfizer Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Pfizer Recent Developments
Table 135. Sivem Pharmaceuticals Corporation Information
Table 136. Sivem Pharmaceuticals Description and Major Businesses
Table 137. Sivem Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 138. Sivem Pharmaceuticals Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Sivem Pharmaceuticals Recent Developments
Table 140. Apotex Corporation Corporation Information
Table 141. Apotex Corporation Description and Major Businesses
Table 142. Apotex Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 143. Apotex Corporation Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Apotex Corporation Recent Developments
Table 145. Auro Pharma Inc Corporation Information
Table 146. Auro Pharma Inc Description and Major Businesses
Table 147. Auro Pharma Inc Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 148. Auro Pharma Inc Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Auro Pharma Inc Recent Developments
Table 150. PLIVA Corporation Information
Table 151. PLIVA Description and Major Businesses
Table 152. PLIVA Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 153. PLIVA Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. PLIVA Recent Developments
Table 155. Jamp Pharma Corporation Corporation Information
Table 156. Jamp Pharma Corporation Description and Major Businesses
Table 157. Jamp Pharma Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 158. Jamp Pharma Corporation Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Jamp Pharma Corporation Recent Developments
Table 160. Nu Pharm Corporation Information
Table 161. Nu Pharm Description and Major Businesses
Table 162. Nu Pharm Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 163. Nu Pharm Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Nu Pharm Recent Developments
Table 165. Codal Synto Corporation Information
Table 166. Codal Synto Description and Major Businesses
Table 167. Codal Synto Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 168. Codal Synto Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Codal Synto Recent Developments
Table 170. Qd Pharmaceuticals Corporation Information
Table 171. Qd Pharmaceuticals Description and Major Businesses
Table 172. Qd Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 173. Qd Pharmaceuticals Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Qd Pharmaceuticals Recent Developments
Table 175. Pharmel Inc Corporation Information
Table 176. Pharmel Inc Description and Major Businesses
Table 177. Pharmel Inc Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 178. Pharmel Inc Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Pharmel Inc Recent Developments
Table 180. Smaart Pharmaceutticals Corporation Information
Table 181. Smaart Pharmaceutticals Description and Major Businesses
Table 182. Smaart Pharmaceutticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 183. Smaart Pharmaceutticals Terbinafine (Lamisil) Product Model Numbers, Pictures, Descriptions and Specifications
Table 184.

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs